The protein kingdom extended: Ordered and intrinsically disordered proteins, their folding, supramolecular complex formation, and aggregation

Progress in Biophysics and Molecular Biology

Volumn 102, Issue 2-3, 2010, Pages 73-84

  Turoverov, Konstantin K ^a   Kuznetsova, Irina M ^a   Uversky, Vladimir N ^b,c  

^a INSTITUTE OF CYTOLOGY   (Russian Federation)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INSTITUTE FOR BIOLOGICAL INSTRUMENTATION   (Russian Federation)

Author keywords

Amorphous aggregates; Amyloid fibrils; Functional amyloid; Globular proteins; Inter and intramolecular contacts; Natively disordered proteins; Protein folding; Protein protein and DNA protein complexes

Indexed keywords

AMYLOID; PROTEIN;

ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN MULTIMERIZATION; REVIEW;

AMYLOID; ANIMALS; HUMANS; MODELS, MOLECULAR; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN MULTIMERIZATION; PROTEINS;

EID: 77954217602     PISSN: 00796107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbiomolbio.2010.01.003     Document Type: Review

References (138)

1. Aigle M., Lacroute F. Genetical aspects of [URE3], a non-mitochondrial, cytoplasmically inherited mutation in yeast. Mol. Gen. Genet. 1975, 136:327-335.
2. Altschuler G.M., Willison K.R. Development of free-energy-based models for chaperonin containing TCP-1 mediated folding of actin. J. R. Soc. Interface 2008, 5:1391-1408.
3. Anfinsen C.B. Principles that govern the folding of protein chains. Science 1973, 181:223-230.
4. Bader M.W., Bardwell J.C. Catalysis of disulfide bond formation and isomerization in Escherichia coli. Adv. Protein Chem. 2001, 59:283-301.
5. Barnhart M.M., Chapman M.R. Curli biogenesis and function. Annu. Rev. Microbiol. 2006, 60:131-147.
6. van den Berg B., Wain R., Dobson C.M., Ellis R.J. Macromolecular crowding perturbs protein refolding kinetics: implications for folding inside the cell. EMBO J. 2000, 19:3870-3875.
7. Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., Shindyalov I.N., Bourne P.E. The protein data bank. Nucleic Acids Res. 2000, 28:235-242.
8. Bucciantini M., Giannoni E., Chiti F., Baroni F., Formigli L., Zurdo J., Taddei N., Ramponi G., Dobson C.M., Stefani M. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 2002, 416:507-511.
9. Bullock A.N., Henckel J., DeDecker B.S., Johnson C.M., Nikolova P.V., Proctor M.R., Lane D.P., Fersht A.R. Thermodynamic stability of wild-type and mutant p53 core domain. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:14338-14342.
10. Chapman M.R., Robinson L.S., Pinkner J.S., Roth R., Heuser J., Hammar M., Normark S., Hultgren S.J. Role of Escherichia coli curli operons in directing amyloid fiber formation. Science 2002, 295:851-855.
11. Chebotareva N.A., Andreeva I.E., Makeeva V.F., Livanova N.B., Kurganov B.I. Effect of molecular crowding on self-association of phosphorylase kinase and its interaction with phosphorylase b and glycogen. J. Mol. Recognit. 2004, 17:426-432.
12. Cheng Y., LeGall T., Oldfield C.J., Dunker A.K., Uversky V.N. Abundance of intrinsic disorder in protein associated with cardiovascular disease. Biochemistry 2006, 45:10448-10460.
13. Cheng Y., Oldfield C.J., Meng J., Romero P., Uversky V.N., Dunker A.K. Mining alpha-helix-forming molecular recognition features with cross species sequence alignments. Biochemistry 2007, 46:13468-13477.
14. Chien P., Weissman J.S., DePace A.H. Emerging principles of conformation-based prion inheritance. Annu. Rev. Biochem. 2004, 73:617-656.
15. Chien P., Weissman J.S. Conformational diversity in a yeast prion dictates its seeding specificity. Nature 2001, 410:223-227.
16. Chiti F. Relative importance of hydrophobicity, net charge and secondary structure propensities in protein aggregation. In protein misfolding, aggregation and conformational diseases. Protein Aggregation and Conformational Diseases 2006, vol. I:43-59. Springer Science+Business Media, LLC, New York. V.N. Uversky, A.L. Fink (Eds.).
17. Chiti F., Dobson C.M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 2006, 75:333-366.
18. Chiti F., Webster P., Taddei N., Clark A., Stefani M., Ramponi G., Dobson C.M. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:3590-3594.
19. Chumakov P.M. Versatile functions of p53 protein in multicellular organisms. Biochemistry (Mosc) 2007, 72:1399-1421.
20. Cohen F.E., Prusiner S.B. Pathologic conformations of prion proteins. Annu. Rev. Biochem. 1998, 67:793-819.
21. Coschigano P.W., Magasanik B. The URE2 gene product of Saccharomyces cerevisiae plays an important role in the cellular response to the nitrogen source and has homology to glutathione s-transferases. Mol. Cell Biol. 1991, 11:822-832.
22. Courchesne W.E., Magasanik B. Regulation of nitrogen assimilation in Saccharomyces cerevisiae: roles of the URE2 and GLN3 genes. J. Bacteriol. 1988, 170:708-713.
23. Coustou V., Deleu C., Saupe S., Begueret J. The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:9773-9778.
24. Deleu C., Clave C., Begueret J. A single amino acid difference is sufficient to elicit vegetative incompatibility in the fungus Podospora anserina. Genetics 1993, 135:45-52.
25. DePace A.H., Santoso A., Hillner P., Weissman J.S. A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion. Cell 1998, 93:1241-1252.
26. Dobson C.M. Protein misfolding, evolution and disease. Trends Biochem. Sci. 1999, 24:329-332.
27. Dolgikh D.A., Gilmanshin R.I., Brazhnikov E.V., Bychkova V.E., Semisotnov G.V., Venyaminov S., Ptitsyn O.B. Alpha-lactalbumin: compact state with fluctuating tertiary structure?. FEBS Lett. 1981, 136:311-315.
28. Dunker A.K., Obradovic Z., Romero P., Garner E.C., Brown C.J. Intrinsic protein disorder in complete genomes. Genome Inform. Ser. Workshop Genome Inform. 2000, 11:161-171.
29. Dunker A.K., Lawson J.D., Brown C.J., Williams R.M., Romero P., Oh J.S., Oldfield C.J., Campen A.M., Ratliff C.M., Hipps K.W., Ausio J., Nissen M.S., Reeves R., Kang C., Kissinger C.R., Bailey R.W., Griswold M.D., Chiu W., Garner E.C., Obradovic Z. Intrinsically disordered protein. J. Mol. Graph Model. 2001, 19:26-59.
30. Dunker A.K., Brown C.J., Lawson J.D., Iakoucheva L.M., Obradovic Z. Intrinsic disorder and protein function. Biochemistry 2002, 41:6573-6582.
31. Dunker A.K., Brown C.J., Obradovic Z. Identification and functions of usefully disordered proteins. Adv. Protein Chem. 2002, 62:25-49.
32. Dunker A.K., Cortese M.S., Romero P., Iakoucheva L.M., Uversky V.N. Flexible nets: the roles of intrinsic disorder in protein interaction networks. FEBS J. 2005, 272:5129-5148.
33. Dunker A.K., Oldfield C.J., Meng J., Romero P., Yang J.Y., Chen J.W., Vacic V., Obradovic Z., Uversky V.N. The unfoldomics decade: an update on intrinsically disordered proteins. BMC Genomics 2008, 9(Suppl. 2):S1.
34. Dunker A.K., Silman I., Uversky V.N., Sussman J.L. Function and structure of inherently disordered proteins. Curr. Opin. Struct. Biol. 2008, 18:756-764.
35. Dunker A.K., Obradovic Z. The protein trinity-linking function and disorder. Nat. Biotechnol. 2001, 19:805-806.
36. Dunker A.K., Uversky V.N. Signal transduction via unstructured protein conduits. Nat. Chem. Biol. 2008, 4:229-230.
37. Dyson H.J., Wright P.E. Coupling of folding and binding for unstructured proteins. Curr. Opin. Struct. Biol. 2002, 12:54-60.
38. Dyson H.J., Wright P.E. Intrinsically unstructured proteins and their functions. Nat. Rev. Mol. Cell Biol. 2005, 6:197-208.
39. Ellis R.J. Macromolecular crowding: obvious but underappreciated. Trends Biochem. Sci. 2001, 26:597-604.
40. Fandrich M., Fletcher M.A., Dobson C.M. Amyloid fibrils from muscle myoglobin. Nature 2001, 410:165-166.
41. Feldman D.E., Frydman J. Protein folding in vivo: the importance of molecular chaperones. Curr. Opin. Struct. Biol. 2000, 10:26-33.
42. Ferron F., Longhi S., Canard B., Karlin D. A practical overview of protein disorder prediction methods. Proteins 2006, 65:1-14.
43. Fink A.L. Chaperone-mediated protein folding. Physiol. Rev. 1999, 79:425-449.
44. Finkelstein A.V., Ptitsyn O.B. Protein Physics: a Course of Lectures 2002, Academic Press, p. 354.
45. Fischer E. Einfluss der Configuration auf die Wirkung der Enzyme. Ber. Dt. Chem. Ges. 1894, 27:2985-2993.
46. Fowler D.M., Koulov A.V., Alory-Jost C., Marks M.S., Balch W.E., Kelly J.W. Functional amyloid formation within mammalian tissue. PLoS Biol. 2006, 4:e6.
47. Fowler D.M., Koulov A.V., Balch W.E., Kelly J.W. Functional amyloid - from bacteria to humans. Trends Biochem. Sci. 2007, 32:217-224.
48. Frokjaer S., Otzen D.E. Protein drug stability: a formulation challenge. Nat. Rev. Drug Discov. 2005, 4:298-306.
49. Fuxreiter M., Simon I., Friedrich P., Tompa P. Preformed structural elements feature in partner recognition by intrinsically unstructured proteins. J. Mol. Biol. 2004, 338:1015-1026.
50. Garner E., Romero P., Dunker A.K., Brown C., Obradovic Z. Predicting binding regions within disordered proteins. Genome Inform. Ser. Workshop Genome Inform. 1999, 10:41-50.
51. Gilbert H.F. Protein chaperones and protein folding. Curr. Opin. Biotechnol. 1994, 5:534-539.
52. +], a heritable prion-like factor of S. Cerevisiae. Cell 1997, 89:811-819.
53. Goers J., Permyakov S.E., Permyakov E.A., Uversky V.N., Fink A.L. Conformational prerequisites for alpha-lactalbumin fibrillation. Biochemistry 2002, 41:12546-12551.
54. Grimmler M., Wang Y., Mund T., Cilensek Z., Keidel E.M., Waddell M.B., Jakel H., Kullmann M., Kriwacki R.W., Hengst L. Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases. Cell 2007, 128:269-280.
55. Gsponer J., Babu M.M. The rules of disorder or why disorder rules. Prog. Biophys. Mol. Biol. 2009, 99:94-103.
56. Gsponer J., Futschik M.E., Teichmann S.A., Babu M.M. Tight regulation of unstructured proteins: from transcript synthesis to protein degradation. Science 2008, 322:1365-1368.
57. Guijarro J.I., Sunde M., Jones J.A., Campbell I.D., Dobson C.M. Amyloid fibril formation by an SH3 domain. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:4224-4228.
58. Hamada D., Segawa S., Goto Y. Non-native alpha-helical intermediate in the refolding of beta-lactoglobulin, a predominantly beta-sheet protein. Nat. Struct. Biol. 1996, 3:868-873.
59. He B., Wang K., Liu Y., Xue B., Uversky V.N., Dunker A.K. Predicting intrinsic disorder in proteins: an overview. Cell Res. 2009, 19:929-949.
60. Hollstein M., Sidransky D., Vogelstein B., Harris C.C. p53 mutations in human cancers. Science 1991, 253:49-53.
61. Huang Y., Liu Z. Kinetic advantage of intrinsically disordered proteins in coupled folding-binding process: a critical assessment of the " fly-casting" mechanism. J. Mol. Biol. 2009, 393:1143-1159.
62. Iakoucheva L.M., Brown C.J., Lawson J.D., Obradovic Z., Dunker A.K. Intrinsic disorder in cell-signaling and cancer-associated proteins. J. Mol. Biol. 2002, 323:573-584.
63. Iakoucheva L.M., Radivojac P., Brown C.J., O'Connor T.R., Sikes J.G., Obradovic Z., Dunker A.K. The importance of intrinsic disorder for protein phosphorylation. Nucleic Acids Res. 2004, 32:1037-1049.
64. Jahn T.R., Radford S.E. The Yin and Yang of protein folding. FEBS J. 2005, 272:5962-5970.
65. Joerger A.C., Fersht A.R. Structural biology of the tumor suppressor p53 and cancer-associated mutants. Adv. Cancer Res. 2007, 97:1-23.
66. Joerger A.C., Fersht A.R. Structure-function-rescue: the diverse nature of common p53 cancer mutants. Oncogene 2007, 26:2226-2242.
67. Joerger A.C., Fersht A.R. Structural biology of the tumor suppressor p53. Annu. Rev. Biochem. 2008, 77:557-582.
68. Kelly J.W. The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr. Opin. Struct. Biol. 1998, 8:101-106.
69. King C.Y., Tittmann P., Gross H., Gebert R., Aebi M., Wuthrich K. Prion-inducing domain 2-114 of yeast Sup35 protein transforms in vitro into amyloid-like filaments. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:6618-6622.
70. Kurahashi H., Ishiwata M., Shibata S., Nakamura Y. A regulatory role of the Rnq1 nonprion domain for prion propagation and polyglutamine aggregates. Mol. Cell Biol. 2008, 28:3313-3323.
71. Kuznetsova I.M., Biktashev A.G., Khaitlina S.Y., Vassilenko K.S., Turoverov K.K., Uversky V.N. Effect of self-association on the structural organization of partially folded proteins: inactivated actin. Biophys. J. 1999, 77:2788-2800.
72. Kuznetsova I.M., Forge V., Turoverov K.K. Structural dynamics, stability and folding of proteins. Tsitologiia 2005, 47:943-952.
73. Lacy E.R., Filippov I., Lewis W.S., Otieno S., Xiao L., Weiss S., Hengst L., Kriwacki R.W. p27 binds cyclin-CDK complexes through a sequential mechanism involving binding-induced protein folding. Nat. Struct. Mol. Biol. 2004, 11:358-364.
74. Levinthal C. Are there pathways for protein folding?. J. Chim. Phys. 1968, 65:44-45.
75. Li X., Romero P., Rani M., Dunker A.K., Obradovic Z. Predicting protein disorder for N-, C-, and internal regions. Genome Inform. Ser. Workshop Genome Inform. 1999, 10:30-40.
76. Lindquist S., Patino M.M., Chernoff Y.O., Kowal A.S., Singer M.A., Liebman S.W., Lee K.H., Blake T. The role of Hsp104 in stress tolerance and [PSI+] propagation in Saccharomyces cerevisiae. Cold Spring Harbor Symp. Quant Biol. 1995, 60:451-460.
77. Maddelein M.L., Dos Reis S., Duvezin-Caubet S., Coulary-Salin B., Saupe S.J. Amyloid aggregates of the HET-s prion protein are infectious. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:7402-7407.
78. Maji S.K., Perrin M.H., Sawaya M.R., Jessberger S., Vadodaria K., Rissman R.A., Singru P.S., Nilsson K.P., Simon R., Schubert D., Eisenberg D., Rivier J., Sawchenko P., Vale W., Riek R. Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science 2009, 325:328-332.
79. Martin-Benito J., Boskovic J., Gomez-Puertas P., Carrascosa J.L., Simons C.T., Lewis S.A., Bartolini F., Cowan N.J., Valpuesta J.M. Structure of eukaryotic prefoldin and of its complexes with unfolded actin and the cytosolic chaperonin CCT. EMBO J. 2002, 21:6377-6386.
80. Midic U., Oldfield C.J., Dunker A.K., Obradovic Z., Uversky V.N. Protein disorder in the human diseasome: unfoldomics of human genetic diseases. BMC Genomics 2009, 10(Suppl. 1):S12.
81. Minton A.P. Implications of macromolecular crowding for protein assembly. Curr. Opin. Struct. Biol. 2000, 10:34-39.
82. Mohan A. MoRFs: a dataset of molecular recognition features. The School of Informatics 2006, 59. Indiana University, Indianapolis.
83. Mostaert A.S., Higgins M.J., Fukuma T., Rindi F., Jarvis S.P. Nanoscale mechanical characterisation of amyloid fibrils discovered in a natural adhesive. J. Biol. Phys. 2006, 32:393-401.
84. Munishkina L.A., Fink A.L., Uversky V.N. Conformational prerequisites for formation of amyloid fibrils from histones. J. Mol. Biol. 2004, 342:1305-1324.
85. Neirynck K., Waterschoot D., Vandekerckhove J., Ampe C., Rommelaere H. Actin interacts with CCT via discrete binding sites: a binding transition-release model for CCT-mediated actin folding. J. Mol. Biol. 2006, 355:124-138.
86. Nelson R., Sawaya M.R., Balbirnie M., Madsen A.O., Riekel C., Grothe R., Eisenberg D. Structure of the cross-beta spine of amyloid-like fibrils. Nature 2005, 435:773-778.
87. Ohgushi M., Wada A. 'Molten-globule state': a compact form of globular proteins with mobile side-chains. FEBS Lett. 1983, 164:21-24.
88. Oldfield C.J., Cheng Y., Cortese M.S., Romero P., Uversky V.N., Dunker A.K. Coupled folding and binding with alpha-helix-forming molecular recognition elements. Biochemistry 2005, 44:12454-12470.
89. Patino M.M., Liu J.J., Glover J.R., Lindquist S. Support for the prion hypothesis for inheritance of a phenotypic trait in yeast. Science 1996, 273:622-626.
90. Pavlov N.A., Cherny D.I., Heim G., Jovin T.M., Subramaniam V. Amyloid fibrils from the mammalian protein prothymosin alpha. FEBS Lett. 2002, 517:37-40.
91. Povarova O.I., Kuznetsova I.M., Turoverov K.K. Different disturbances - one pathway of protein unfolding. Actin folding-unfolding and misfolding. Cell Biol. Int. 2007, 31:405-412.
92. Ptitsyn O.B. Stages in the mechanism of self-organization of protein molecules. Dokl Akad Nauk SSSR 1973, 210:1213-1215.
93. Ptitsyn O.B. Molten globule and protein folding. Adv. Protein Chem. 1995, 47:83-229.
94. Radford S.E. Protein folding: progress made and promises ahead. Trends Biochem. Sci. 2000, 25:611-618.
95. Radivojac P., Iakoucheva L.M., Oldfield C.J., Obradovic Z., Uversky V.N., Dunker A.K. Intrinsic disorder and functional proteomics. Biophys. J. 2007, 92:1439-1456.
96. Receveur-Brechot V., Bourhis J.M., Uversky V.N., Canard B., Longhi S. Assessing protein disorder and induced folding. Proteins 2006, 62:24-45.
97. Reeves R., Beckerbauer L. HMGI/Y proteins: flexible regulators of transcription and chromatin structure. Biochim. Biophys. Acta 2001, 1519:13-29.
98. Romero, P., Obradovic, Z., Kissinger, C.R., Villafranca, J.E., Dunker, A.K., 1997. Identifying disordered regions in proteins from amino acid sequences. IEEE Int. Conf. Neural Netw., vol. 1, pp. 90-95.
99. Sawaya M.R., Sambashivan S., Nelson R., Ivanova M.I., Sievers S.A., Apostol M.I., Thompson M.J., Balbirnie M., Wiltzius J.J., McFarlane H.T., Madsen A.O., Riekel C., Eisenberg D. Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature 2007, 447:453-457.
100. Schmid F.X. Prolyl isomerases. Adv. Protein Chem. 2001, 59:243-282.
101. Schultz C.P. Illuminating folding intermediates. Nat. Struct. Biol. 2000, 7:7-10.
102. Serio T.R., Lindquist S.L. [PSI+]: an epigenetic modulator of translation termination efficiency. Annu. Rev. Cell Dev. Biol. 1999, 15:661-703.
103. Serpell L.C., Sunde M., Blake C.C. The molecular basis of amyloidosis. Cell Mol. Life Sci. 1997, 53:871-887.
104. Shoemaker B.A., Portman J.J., Wolynes P.G. Speeding molecular recognition by using the folding funnel: the fly-casting mechanism. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:8868-8873.
105. Sondheimer N., Lindquist S. Rnq1: an epigenetic modifier of protein function in yeast. Mol. Cell 2000, 5:163-172.
106. Stansfield I., Jones K.M., Kushnirov V.V., Dagkesamanskaya A.R., Poznyakovski A.I., Paushkin S.V., Nierras C.R., Cox B.S., Ter-Avanesyan M.D., Tuite M.F. The products of the SUP45 (eRF1) and SUP35 genes interact to mediate translation termination in Saccharomyces cerevisiae. EMBO J. 1995, 14:4365-4373.
107. Tanford C. Protein denaturation. Adv. Protein Chem. 1968, 23:121-282.
108. Ter-Avanesyan M.D., Dagkesamanskaya A.R., Kushnirov V.V., Smirnov V.N. The SUP35 omnipotent suppressor gene is involved in the maintenance of the non-Mendelian determinant [psi+] in the yeast Saccharomyces cerevisiae. Genetics 1994, 137:671-676.
109. Tompa P. Intrinsically unstructured proteins. Trends Biochem. Sci. 2002, 27:527-533.
110. Tompa P. The interplay between structure and function in intrinsically unstructured proteins. FEBS Lett. 2005, 579:3346-3354.
111. True H.L., Berlin I., Lindquist S.L. Epigenetic regulation of translation reveals hidden genetic variation to produce complex traits. Nature 2004, 431:184-187.
112. True H.L., Lindquist S.L. A yeast prion provides a mechanism for genetic variation and phenotypic diversity. Nature 2000, 407:477-483.
113. Uversky V.N. Natively unfolded proteins: a point where biology waits for physics. Protein Sci. 2002, 11:739-756.
114. Uversky V.N. What does it mean to be natively unfolded?. Eur. J. Biochem. 2002, 269:2-12.
115. Uversky V.N. Protein folding revisited. A polypeptide chain at the folding-misfolding-nonfolding cross-roads: which way to go?. Cell Mol. Life Sci. 2003, 60:1852-1871.
116. Uversky V.N. Alpha-synuclein misfolding and neurodegenerative diseases. Curr. Protein Pept. Sci. 2008, 9:507-540.
117. Uversky V.N. Intrinsic disorder in proteins associated with neurodegenerative diseases. Frontiers in Bioscience 2009, 14:5188-5238.
118. Uversky V.N. Intrinsically disordered proteins and their environment: effects of strong denaturants, temperature, pH, counter ions, membranes, binding partners, osmolytes, and macromolecular crowding. Protein J. 2009, 28:305-325.
119. Uversky V.N., Cooper E.M., Bower K.S., Li J., Fink A.L. Accelerated alpha-synuclein fibrillation in crowded milieu. FEBS Lett. 2002, 515:99-103.
120. Uversky V.N., Dunker A.K. Biochemistry. Controlled chaos. Science 2008, 322:1340-1341.
121. Uversky V.N., Fernandez A., Fink A.L. Structural and conformational prerequisites of amyloidogenesis. Protein Aggregation and Conformational Diseases 2006, vol. I:1-20. Springer Science+Business Media, LLC, New York. V.N. Uversky, A.L. Fink (Eds.).
122. Uversky V.N., Gillespie J.R., Fink A.L. Why are " natively unfolded" proteins unstructured under physiologic conditions?. Proteins 2000, 41:415-427.
123. Uversky V.N., Oldfield C.J., Dunker A.K. Showing your ID: intrinsic disorder as an ID for recognition, regulation and cell signaling. J. Mol. Recognit. 2005, 18:343-384.
124. Uversky V.N., Oldfield C.J., Dunker A.K. Intrinsically disordered proteins in human diseases: introducing the D2 concept. Annu. Rev. Biophys. 2008, 37:215-246.
125. Uversky V.N., Oldfield C.J., Midic U., Xie H., Xue B., Vucetic S., Iakoucheva L.M., Obradovic Z., Dunker A.K. Unfoldomics of human diseases: linking protein intrinsic disorder with diseases. BMC Genomics 2009, 10(Suppl. 1):S7.
126. Vacic V., Oldfield C.J., Mohan A., Radivojac P., Cortese M.S., Uversky V.N., Dunker A.K. Characterization of molecular recognition features, MoRFs, and their binding partners. J. Proteome Res. 2007, 6:2351-2366.
127. Varshavsky Y.M. On the dynamic aspects of the spatial structure of biopolymers. Physical Methods for the Analysis of Molecular and Supramolecular Structures 1979, 58-71. Nauka, Moscow. Y.M. Varshavsky (Ed.).
128. Vucetic S., Xie H., Iakoucheva L.M., Oldfield C.J., Dunker A.K., Obradovic Z., Uversky V.N. Functional anthology of intrinsic disorder. 2. Cellular components, domains, technical terms, developmental processes, and coding sequence diversities correlated with long disordered regions. J. Proteome Res. 2007, 6:1899-1916.
129. Wang W. Protein aggregation and its inhibition in biopharmaceutics. Int. J. Pharm. 2005, 289:1-30.
130. Ward J.J., Sodhi J.S., McGuffin L.J., Buxton B.F., Jones D.T. Prediction and functional analysis of native disorder in proteins from the three kingdoms of life. J. Mol. Biol. 2004, 337:635-645.
131. Wickner R.B. [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 1994, 264:566-569.
132. Willison K.R., Grantham J. The role of cytosolic chaperonin, CCT, in normal eukaryotic cell growth. Molecular Chaperones in the Cell: Frontiers in Molecular Biology 2001, 90-118. Oxford University Press, Oxford. P. Lund (Ed.).
133. Wiltzius J.J., Landau M., Nelson R., Sawaya M.R., Apostol M.I., Goldschmidt L., Soriaga A.B., Cascio D., Rajashankar K., Eisenberg D. Molecular mechanisms for protein-encoded inheritance. Nat. Struct. Mol. Biol. 2009, 16:973-978.
134. Wright P.E., Dyson H.J. Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. J. Mol. Biol. 1999, 293:321-331.
135. Wright P.E., Dyson H.J. Linking folding and binding. Curr. Opin. Struct. Biol. 2009, 19:31-38.
136. Xie H., Vucetic S., Iakoucheva L.M., Oldfield C.J., Dunker A.K., Obradovic Z., Uversky V.N. Functional anthology of intrinsic disorder. 3. Ligands, post-translational modifications, and diseases associated with intrinsically disordered proteins. J. Proteome Res. 2007, 6:1917-1932.
137. Xie H., Vucetic S., Iakoucheva L.M., Oldfield C.J., Dunker A.K., Uversky V.N., Obradovic Z. Functional anthology of intrinsic disorder. 1. Biological processes and functions of proteins with long disordered regions. J. Proteome Res. 2007, 6:1882-1898.
138. Zimmerman S.B., Minton A.P. Macromolecular crowding: biochemical, biophysical, and physiological consequences. Annu. Rev. Biophys. Biomol. Struct. 1993, 22:27-65.